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Fibronectin (Fn) binds to a  large number of natural and artificial substrates 
such as collagen, fibrin, and plastic (1), and the resulting substrate-bound Fn is 
then  recognized by cells.  Upon  contact, fibroblasts and many other cell  types 
spread  rapidly on  Fn-coated surfaces (2).  The  effects of Fn  on  cells  are  not 
limited to the immediate motile response of spreading, since attachment to Fn 
alters the growth of tumor cells and the course of differentiation of embryonic 
cells  (2). In human macrophages, interaction with Fn causes receptors for the 
third  component of complement, C3,  to avidly promote phagocytosis of both 
C3b- and C3bi-coated particles (3, 4). The receptors for C3b and C3bi (CR1  and 
CR3,  respectively) mediate the binding but not the phagocytosis of C3b- and 
C3bi-coated particles if macropbages are spread on surfaces devoid of Fn. The 
"activation" of complement receptors by Fn occurs rapidly (within 45  min), is 
completely reversible, and is not accompanied by a change in the number of C3b 
or C3bi receptor molecuels on the surface of the phagocyte (5). 
The Fn molecule is composed of several folding domains that confer on it the 
ability to bind to other surface-bound molecules (1). The domain of Fn recog- 
nized by cells  is comprised of 108  amino acids and occurs  ~150  amino acids 
from the amino terminal (6,  7).  Pierschbacber et al.  (8,  9) have shown that the 
segment  of the  cell-binding domain  of Fn  recognized  by  normal  rat  kidney 
(NRK) cells  comprises only a  short sequence of amino acids: Arg-Gly-Asp-Ser 
(RGDS).  Soluble synthetic peptides containing the RGDS sequence inhibit the 
attachment of NRK cells to Fn-coated surfaces, and surfaces coated with peptides 
containing the  RGDS  sequence  support  the  attachment of NRK  cells  (8,  9). 
Peptides in which the R, G, or D residues are replaced by other amino acids are 
not recognized by NRK cells, though certain amino acids may be substituted for 
S without destroying the ability of the peptide to be recognized (9,  10). Recog- 
nition of RGDS  by  NRK cells  is  mediated by a  140,000  dalton protein  that 
appears to be the Fn receptor (11).  RGD sequences are also recognized by other 
receptors  that  promote  cell  adhesion,  since  the  adhesion  of Dictyostelium  to 
Discoidin  I  (12)  and  of NRK cells  to  vitrionectin (13)  can  be  inhibited  with 
soluble,  RGD-containing peptides.  Further,  several  ligands  that  promote  cell 
attachment,  such  as  Discoidin  I,  collagens,  and  fibrinogen,  possess  RGD  se- 
quences  (10).  Receptors  that  mediate cell-cell  interaction  may also  recognize 
This work was supported by grant AI22003 from the U.S. Public Health Service and grant JRFA- 
103 from the American Cancer Society. 
762  J. Exp. MElt. © The Rockefeller  University  Press . 0022-1007/85/08/0762/06 $1.00 
Volume 162  August 1985  762-767 WRIGHT  AND  MEYER  BRIEF  DEFINITIVE  REPORT  763 
RGD since soluble,  RGD-containing peptides inhibit proper movement of cells 
during the development of avian and amphibian embryos (14). 
Here  we  show  that  the  Fn  receptor of human  macrophages  recognizes the 
RGDS  sequence.  Attachment  of macrophages  to  surfaces  coated with  RGDS- 
containing peptides enables both the C3b and the C3bi receptors of the attached 
macrophages to promote phagocytosis, and soluble,  RGDS-containing peptides 
competitively inhibit the activation of C3 receptors by surface-bound Fn. Ligation 
of Fn receptors by soluble, monomeric peptides, however, is insufficient to cause 
activation  of  C3  receptors.  In  contrast  to  Fn  receptors,  the  binding  of  C3 
receptors  to  their  ligands  is  not  inhibited  by  RGDS-containing  peptides  even 
though the ligands, C3b and C3bi, do contain an RGD sequence. 
Materials and Methods 
Reagents.  The synthetic peptides GRGDSP, GRGESP (10), peptide I, and peptide IV 
(8)  were a  generous gift of Drs.  M.  Pierschbacher and  E.  Ruoslahti.  Fibronectin was 
purchased from the Greater New York Blood Center. 
Cells.  Human monocytes were purified on Percoll gradients and cultured in Teflon 
beakers as previously described (15). Such cells mature in culture, and after 5-10 d they 
closely resemble macrophages. These cells are referred to here as MO. Human neutrophils 
(PMN) were purified on  Ficoll-Hypaque gradients (16).  Sheep erythrocytes (E) coated 
with IgM (EIgM), IgG (EIgG), C3b (EC3b), or C3bi (EC3bi) were prepared as described 
(15). 
Substrates.  Plastic tissue culture surfaces were coated with proteins or synthetic pep- 
tides by passive  adsorption. Peptides or proteins dissolved in phosphate-buffered saline 
(17) deficient in Ca  ++ and Mg  +÷ (PD) were incubated with new, dry culture surfaces for 2 
h at 20°C. The coating reagents were used at the following concentrations: Fn, 100 #g/ 
ml; human  serum albumin  (HSA),  500  #g/ml;  synthetic peptides,  50  ug/ml.  In  some 
experiments, a  relatively light  coating  of Fn  was  obtained  by incubating  the  culture 
surfaces with a solution containing 50 t~g/ml Fn and 50 t~g/ml HSA. 
Assays of Attachment and Phagocytosis.  Monolayers of MO or PMN were obtained by 
incubating suspensions of phagocytes with the ligand-coated surfaces for 45 min at 37 °C 
as described (5).  The monolayers were washed,  ligand-coated E were added,  and the 
monolayers were reincubated at 37 ° C. Assays of attachment were read after 15 min, and 
assays of phagocytosis after 45 rain at 37 °C as previously described (15). The number of 
attached  or  ingested  erythrocytes per  100  phagocytes  is  termed  the  attachment  or 
phagocytic index, respectively. 
Results and Discussion 
RGDS-containing Peptides Do Not Bind to Complement  Receptors.  The deduced 
sequence of human C3 contains the sequence RGDQ, 267 amino acids from the 
C  terminus  (amino  acids  1393-1396)  (18).  This  segment  resides  in  the  alpha 
polypeptide of C3  and is present in C3b and C3bi but not C3d.  It was thus of 
interest to see whether RGDS-containing peptides could inhibit the binding of 
either C3b or C3bi to their respective receptors. Table I shows that the peptide, 
GRGDSP,  at  a  concentration  of  1.5  mg/ml  is  not  capable  of  competitively 
inhibiting either the C3b or the C3bi receptors expressed on MO or PMN. The 
binding assay  was  performed  using  a  brief incubation  of phagocytes with  C3- 
coated erythrocytes so that the binding was approximately half-maximal and  a 
modest inhibition could have been noted. The observation that RGDS-containing 
peptides did not inhibit the binding of C3-coated erythrocytes to MO does not 
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TABLE  I 
Interaction  of C3b and C3bi with their Receptors on MO Is Not 
Inhibited  by Soluble, RGDS-containing  Peptides 
Attachment index 
Competitor  MO  PMN 
EC3b  EC3bi  EC3b  EC3bi 
--  1,031 (100)  909 (100)  353 (94)  198 (74) 
GRGDSP  1,096 (100)  823 (100)  341  (94)  230 (73) 
GRGESP  1,104 (100)  886 (100)  360 (89)  209 (76) 
MO (cultured 7 d in Teflon beakers) or freshly isolated PMN were allowed 
to spread on HSA-coated tissue culture surfaces for 45 rain at 37°C. The 
resulting monolayers were then washed and incubated at 37 °C for 15 rain 
with the indicated C3-coated erythrocytes in the presence of 1.5 mg/ml 
GRGDSP, GRGESP, or without added competitor. The attachment index 
was then measured as described in Materials and Methods. The percent 
of phagocytes binding at least one erythrocyte is given in  parentheses. 
These results are representative of four separate experiments. 
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FIGURE  1.  Substrate-bound, RGDS-containing peptides enhance the phagocytosis of C3b- 
and C3bi-coated erythrocytes. The indicated peptides were attached to plastic culture surfaces 
as described in  Materials and  Methods.  MO (5-d cultures) were allowed to spread on  the 
coated surface for 45 min at 37°C, and then the phagocytosis of EC3b (open bars) or EC3bi 
(hatched bars) was measured. 
sequence in C3, since the conformation of that sequence may be poorly mimicked 
by GRGDSP.  However,  it is certain that neither C3b nor C3bi receptors recog- 
nize the  RGDS sequence as it appears in Fn, since the concentrations of RGDS- 
containing peptides in Table  I  did inhibit the binding of Fn to Fn receptors (see 
below).  Further,  neither  C3b  nor  C3bi  receptors exhibited reduced  activity in 
MO  spread on  Fn- or RGDS-coated  surfaces (3;  Fig.  1,  and data not shown).  A 
reduction  in  C3  receptor  activity would  be  expected  if complement  receptors 
bound  to  Fn or RGDS,  because such  binding would cause  redistribution of C3 
receptors to the substrate-at[ached portion of the MO and subsequent diminution 
of receptor activity on the apical surface of the MO. Thus we believe that neither 
the C3b nor the C3bi receptors recognize the RGDS sequences in Fn, and neither WRIGHT  AND  MEYER  BRIEF  DEFINITIVE  REPORT  765 
receptor is inhibited by concentrations of GRGDSP <1  mg/ml. 
Activation of Complement Receptor Activity by Synthetic Peptides.  The capacity of 
peptides  from  the  ceil-binding  domain  of Fn  to  mimic  the  enhancement  of 
complement-mediated  phagocytosis  caused  by  Fn  was  determined.  Synthetic 
peptides were first attached to culture surfaces. MO were then allowed to spread 
on the peptide-coated surface, and  the phagocytosis-promoting activity of C3b 
and C3bi receptors was measured (Fig.  1). A  30 amino acid peptide from the C- 
terminal  region  of the  cell attachment  domain  of Fn  (peptide IV) was fully as 
active as whole Fn in enhancing complement-mediated phagocytosis. This peptide 
bears  the  RGDS  sequence previously shown  to  interact  with  Fn  receptors  on 
NRK cells (8).  In contrast, a  30 amino acid peptide from the amino terminal  of 
the cell attachment domain (peptide I) had no effect on the function of comple- 
ment receptors.  To further define the region of Fn recognized by MO, shorter 
peptides  were  used.  The  peptide  GRGDSP  fully  activated  the  phagocytosis- 
promoting capacity of both the C3b and the C3bi receptors (Fig.  1). The high 
specificity for the recognition of this peptide is indicated by the observation that 
peptide GRGESP, in which glutamic acid is substituted for aspartic acid, is unable 
to activate C3-mediated phagocytosis. These experiments demonstrate that MO 
recognize a  short RGDS-containing sequence in the cell-binding domain of Fn, 
and  that  ligation  of receptors  on  MO  by  substrate-bound  RGDS-containing 
peptides is sufficient to activate C3 receptors. 
Soluble RGDS-containing Peptides Inhibit the Action of Fn on MO.  To determine 
whether interaction with RGDS-containing sequences is necessary for activation 
of C3 receptors by Fn, MO were allowed to spread on Fn-coated surfaces in the 
presence  of soluble  RGDS-containing  peptides,  and  phagocytosis  of C3b and 
C3bi-coated erythrocytes was measured in the continued presence of the peptides 
(Fig. 2, a and b). None of the peptides tested inhibited the attachment of MO to 
the substrates (data not shown). This result is expected since MO do not depend 
on Fn for adhesion and can spread on nearly any surface except Teflon. Peptide 
GRGDSP  did,  however,  cause  a  dose-dependent  inhibition  of  Fn-stimulated 
phagocytosis  of both  EC3b  (Fig.  2a)  and  EC3bi  (Fig.  2b).  Similar  doses  of 
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FIGURE  2.  Soluble,  RGDS-containing peptides inhibit the action of Fn on  MO.  MO (10-d 
cultures) were allowed to spread on Fn-coated surfaces for 45 rain at 37 °C in the presence of 
various concentrations  of peptides.  C3-coated  erythrocytes  were  then  added  and,  after  an 
additional 45 rain at 37°C, phagocytosis was scored. In these experiments, the surfaces were 
coated with a  mixture of HSA and Fn to lessen the concentration of substrate-bound Fla.  (A) 
Phagocytosis of EC3b. (B) Phagocytosis of EC3bi. 766  WRIGHT AND  MEYER  BRIEF  DEFINITIVE REPORT 
GRGESP did not inhibit phagocytosis of complement-coated erythrocytes (Fig. 
2, a and b), suggesting that the inhibitory effect of GRGDSP is mediated by the 
RGDS  sequence.  In  a  parallel  fashion, peptide  IV,  which contains an  RGDS 
sequence, inhibited the effect of Fn but peptide I, which does not contain RGDS, 
did not. 
Neither GRGDSP nor peptide IV inhibited the phagocytosis of EIgG (data not 
shown), confirming that they do not cause a  general paralysis of phagocytosis 
but only halt the enhancement of C3-mediated phagocytosis caused by interaction 
of MO  with  Fn.  Thus,  interaction  of MO  with an  RGDS  sequence  in  Fn  is 
necessary for Fn to augment C3-mediated phagocytosis. 
GRGDSP and peptide IV inhibited the action of Fn receptors (Fig. 2), presum- 
ably because they bind the Fn receptors of MO. It is of interest that binding of 
such monomeric, RGDS-containing peptides does not enhance the function of 
complement receptors  (Fig.  2,  and data not shown).  This result confirms our 
earlier finding (3) that soluble Fn does not activate complement receptors and 
indicates that, for Fn  receptors to transduce signals to the MO,  the receptors 
must be ligated by surface-bound ligands. The requirement that receptors be, in 
some way, crosslinked to transduce signals is shared by the majority of receptors 
for peptide hormones (19).  In physiological terms, this suggests that complement 
receptors are not activated in vivo by the high levels of Fn in plasma, but are 
only activated at sites  where  Fn  is deposited on a  surface.  Since  Fn  binds to 
fibrin, denatured collagen, and bacteria, it is likely to be deposited at sites of 
wounding or infection, where enhanced phagocytic activity is called for. 
Summary 
When  cultured  human  monocytes (MO)  were  spread  on  fibronectin  (Fn)- 
coated surfaces, C3 receptors on the MO exhibited markedly enhanced capacity 
to promote phagocytosis. The activation of C3 receptors by Fn was mediated by 
a receptor that recognizes a sequence, Arg-Gly-Asp-Ser (RGDS), present in the 
cell-binding domain  of Fn.  Soluble,  RGDS-containing peptides  inhibited  the 
activation  of C3  receptors  caused  by  surface-bound  Fn,  and  surface-bound, 
RGDS-containing peptides themselves caused activation of the C3 receptors of 
attached MO. Although soluble, RGDS-containing peptides bound to Fn recep- 
tors, such monovalent ligation was insufficient to activate C3 receptors. 
Received  for publication  14 May 1985. 
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